Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

675 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of adult acute lymphoblastic leukemia.
Gökbuget N, Hoelzer D. Gökbuget N, et al. Among authors: hoelzer d. Hematology Am Soc Hematol Educ Program. 2006:133-41. doi: 10.1182/asheducation-2006.1.133. Hematology Am Soc Hematol Educ Program. 2006. PMID: 17124052 Review.
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib.
Wassmann B, Pfeifer H, Scheuring UJ, Binckebanck A, Gökbuget N, Atta J, Brück P, Rieder H, Schoch C, Leimer L, Schwerdtfeger R, Ehninger G, Lipp T, Perz J, Stelljes M, Gschaidmeier H, Hoelzer D, Ottmann OG. Wassmann B, et al. Among authors: hoelzer d. Blood. 2004 Feb 15;103(4):1495-8. doi: 10.1182/blood-2003-01-0154. Epub 2003 Oct 23. Blood. 2004. PMID: 14576058 Free article. Clinical Trial.
Developing a European network for adult ALL.
Gökbuget N, Bassan R, Dekker A, Dombret H, Foà R, Ifrah N, Kovacsovics T, Labar B, Mandelli F, Meloni G, Ribera JM, Smedmyr B, Vernant JP, Walewski J, Willemze R, Hoelzer D; European Working Group for Adults ALL (EWALL). Gökbuget N, et al. Among authors: hoelzer d. Hematol J. 2004;5 Suppl 3:S46-52. doi: 10.1038/sj.thj.6200422. Hematol J. 2004. PMID: 15190278 No abstract available.
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
Brüggemann M, Raff T, Flohr T, Gökbuget N, Nakao M, Droese J, Lüschen S, Pott C, Ritgen M, Scheuring U, Horst HA, Thiel E, Hoelzer D, Bartram CR, Kneba M; German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia. Brüggemann M, et al. Among authors: hoelzer d. Blood. 2006 Feb 1;107(3):1116-23. doi: 10.1182/blood-2005-07-2708. Epub 2005 Sep 29. Blood. 2006. PMID: 16195338 Free article. Clinical Trial.
Treatment of adult acute lymphoblastic leukemia.
Gökbuget N, Hoelzer D. Gökbuget N, et al. Among authors: hoelzer d. Semin Hematol. 2009 Jan;46(1):64-75. doi: 10.1053/j.seminhematol.2008.09.003. Semin Hematol. 2009. PMID: 19100369 Review.
675 results